Cancer screening participation among women with type 2 diabetes V1
Research type
Research Study
Full title
Diabetes-related barriers and facilitators to cancer screening in women with type 2 diabetes: An in-depth qualitative interview study
IRAS ID
304046
Contact name
Rebecca Spencer
Contact email
Sponsor organisation
Leeds Beckett University
Duration of Study in the UK
1 years, 5 months, 31 days
Research summary
Background
People with type 2 diabetes (T2DM) are at an increased risk of developing certain types of cancer, including breast and colorectal cancer. Individuals with cancer and comorbid diabetes are more likely to experience adverse events (e.g. hospitalisations, infections, chemotherapy reductions/stoppages, cancer recurrences) and are more likely to die from cancer. One way to improve cancer-related outcomes is through the routine screening of asymptomatic individuals. Despite being at an increased risk from cancer, women with diabetes are less likely to participate in cancer screening, compared to women without diabetes. Previous research has indicated the existence of diabetes-related barriers to cancer screening. However, no research has been conducted to elucidate these diabetes-related barriers and understand how they could be addressed.Aims
To explore the diabetes-related barriers and facilitators to participating in cancer screening, that women with T2DM experience.
To identify ways to improve informed decision making about and participation in cancer screening, among women with T2DM.Methods
We will interview up to 25 women, aged 50 to 74, who live in England (who are therefore eligible to receive at least one type of routine NHS cancer screening - breast, bowel and/or cervical screening) and have T2DM. Interviews will explore participants’ experiences of/perspectives on cancer screening, with a particular focus on identifying perceived diabetes-related barriers and facilitators to cancer screening and potential ways to address these barriers and/or promote the facilitators. Interviews are expected to last around 30 to 60 minutes and will be audio-recorded. The data will be analysed using ‘framework analysis’.Outputs
Study findings will be shared through peer-reviewed journal articles, lay summaries and presentations at academic and patient and public conferences, events and meetings. The findings may be used to inform future research, which could aim to develop and evaluate intervention strategies to address diabetes-related barriers to cancer screening.REC name
North East - Tyne & Wear South Research Ethics Committee
REC reference
22/NE/0037
Date of REC Opinion
8 Mar 2022
REC opinion
Favourable Opinion